Beam Therapeutics
BEAM----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Beam Therapeutics(BEAM) predict that the Revenue is 31.74 M (+324.9%), Beat estimate;the EBIT is -107.22 M (+10.12%), Beat estimate;the EPS is -0.91 (+26.61%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.03B324.87%
0.01B63.60%
+0.02B261.27%
EBITExceed expectations
-0.11B10.12%
-0.12B1.99%
+0.01B12.11%
EPSExceed expectations
-0.9126.61%
-1.016618.02%
+0.10668.59%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf